ENDRA Life Sciences (NDRA) Tax Provisions (2020 - 2024)
ENDRA Life Sciences' (NDRA) quarterly Tax Provisions came in at -$2.4 million in Q4 2024, up 1.86% quarter-over-quarter from -$2.5 million in Q4 2020.
Analysis
ENDRA Life Sciences (NDRA) Tax Provisions (2020 - 2024) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Tax Provisions for 2 consecutive years, with -$2.4 million the latest figure, recorded in Q4 2024.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to -$2.4 million in Q4 2024; TTM through Jun 2025 was -$2.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.5 million, up 38.93% from the prior year.
- Tax Provisions was -$2.4 million for Q4 2024 at ENDRA Life Sciences, up from -$2.5 million in the prior quarter.
- Over five years, Tax Provisions peaked at -$2.4 million in Q4 2024 and troughed at -$2.5 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 119.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 18.80 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 22,000.00 |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -1.60 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 300,000.00 |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | - |